Detailed price information for Rapport Therapeutics Inc (RAPP-Q) from The Globe and Mail including charting and trades.

When "newborn jitters" turned out to be a rare brain condition, Veronica Monclova fought for the surgery that saved her daughter’s life.

Teacher Yareli Jessica Gijon tells PEOPLE how she manages epilepsy in the classroom and why she posted a seizure video to ...

Drug-resistant epilepsy affects millions of people worldwide and remains one of the most difficult neurological disorders to treat. For patients whose seizures continue despite medication, surgical ...

Abstract: In this work, we propose a novel hybrid architecture for epileptic seizure prediction, utilizing a deep learning approach by stacking the convolutional neural network (CNN) and bidirectional ...

Bristol Myers Squibb's big buys: $18.1 billion in 2 biotech deals Xenon Pharmaceuticals (NASDAQ:XENE) said it is preparing to ...

Angelini Pharma is acquiring Catalyst Pharmaceuticals in a $4.1 billion transaction that expands its presence in the US rare ...

Reported positive topline data from Phase 3 X-TOLE2 study of azetukalner in FOS in March and anticipate NDA submission in Q3 2026Five additional Phase 3 studies of azetukalner continue to enroll in ep ...

Focal Bathys MG delivers top-tier wireless sound with upgraded ANC, premium comfort, and detail but at $1,499, rivals like Sony, Bowers & Wilkins, and DALI push hard. I said it on our 100th podcast: ...

Reported positive topline data from Phase 3 X-TOLE2 study of azetukalner in FOS in March and anticipate NDA submission in Q3 2026Five additional ...

Consideration is set at $31.50 per Catalyst share in cash, implying an equity value above $4.1 billion and a 21% premium to ...

Epilepsy is a neurological disorder that causes temporary brain dysfunction. The aftermath of an epileptic seizure varies for each individual and depends on its severity. FITBOOK outlines types of ...